Species: Hoylesella nanceiensis (HMT-0299) Primary Body Site: Oral
Download Options
LINKS: Ecology Home
| HMT-0299: [Body Sites Data]
[Taxon Description]
| Life Page: Hoylesella nanceiensis
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.04 | 0.03 | 0.03 | 1.17 | 0.17 | 1.45 | 1.49 | 1.02 | 0.85 | 0.75 | 0.03 | 0 | 0 | 0.06 | 0.01 | 0.01 | 0.02 | 0 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0.01 | 0 | 0.01 | 0.01 | 0.01 | 1.45 | 0.23 | 0.14 | 0.10 | 0.07 | 0 | 0 | 0 | 0.06 | 0 | 0 | 0 | 0 |
| 90thp | 0.07 | 0.06 | 0.06 | 3.13 | 0.34 | 1.45 | 2.60 | 1.83 | 1.92 | 1.84 | 0.04 | 0 | 0 | 0.06 | 0.03 | 0.02 | 0.02 | 0.01 |
| Stdev | 0.03 | 0.07 | 0.03 | 2.56 | 0.37 | 0 | 1.24 | 0.77 | 0.86 | 0.98 | 0.06 | 0 | 0 | 0 | 0.02 | 0.02 | 0.10 | 0.01 |
| Prev(%) | 12.50 | 18.48 | 0 | 60.00 | 32.20 | 100.00 | 75.00 | 100.00 | 77.27 | 92.20 | 3.08 | 0 | 0 | 0 | 0 | 0 | 1.06 | 0 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.01 | 0.01 | 0.42 | 0.19 | 0.49 | 0.99 | 0.38 | 0.42 | 0.76 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.04 | 0.05 | 1.17 | 0.52 | 1.19 | 2.38 | 0.98 | 1.05 | 1.72 | 0 |
| Stdev | 0.02 | 0.03 | 0.99 | 0.32 | 0.53 | 1.24 | 0.49 | 0.53 | 1.07 | 0 |
| Prev(%) | 31.17 | 25.97 | 48.05 | 80.52 | 88.31 | 88.31 | 83.12 | 87.01 | 89.61 | 1.30 |
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.03 | 0.03 | 0.35 | 0.29 | 0.77 | 1.66 | 0.56 | 0.61 | 1.24 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0.04 | 0.10 | 0 | 0 | 0.01 | 0 |
| 90thp | 0.08 | 0.08 | 0.86 | 0.69 | 1.83 | 3.96 | 1.32 | 1.46 | 2.98 | 0 |
| Stdev | 0.10 | 0.08 | 0.82 | 0.51 | 1.05 | 2.50 | 0.70 | 0.82 | 1.92 | 0 |
| Prev(%) | 29.05 | 31.08 | 61.49 | 86.49 | 91.89 | 94.59 | 83.11 | 89.19 | 89.86 | 1.40 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0 | 0.36 | 0.20 | 0.55 | 0.92 | 0.46 | 0.52 | 0.66 | 0.02 | 0.01 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 1.24 | 0.55 | 1.29 | 2.32 | 1.12 | 1.40 | 1.64 | 0.03 | 0.01 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0 | 0 | 0.77 | 0.32 | 0.76 | 1.19 | 0.68 | 0.74 | 0.96 | 0.11 | 0.07 | 0 | 0.10 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 0 | 0 | 66.43 | 76.71 | 86.58 | 86.92 | 84.23 | 87.33 | 88.39 | 14.33 | 11.78 | 0 | 15.52 | 0 | 0 | 0 | 0 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.03 | 0 | 0.65 | 0.46 | 1.18 | 1.59 | 0.74 | 0.76 | 1.16 | 0 | 0.09 | 0.07 | 0.19 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0.08 | 0 | 0.02 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.10 | 0 | 2.09 | 1.21 | 2.73 | 3.71 | 1.89 | 1.77 | 2.69 | 0 | 0.02 | 0.01 | 0.24 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.08 | 0 | 1.26 | 0.70 | 1.59 | 2.13 | 1.01 | 1.16 | 1.65 | 0 | 0.51 | 0.50 | 0.86 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 38.77 | 0 | 65.68 | 80.89 | 89.77 | 92.56 | 83.80 | 91.73 | 93.19 | 0 | 12.74 | 11.11 | 22.07 | 0 | 0 | 0 | 0 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0.01 | 0.01 | 0.07 | 0.14 | 0.19 | 0.93 | 0.31 | 0.26 | 0.27 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0 | 0.01 | 0 |
| 90thp | 0.01 | 0.02 | 0.16 | 0.38 | 0.34 | 3.15 | 0.55 | 0.69 | 0.59 | 0 |
| Stdev | 0.01 | 0.04 | 0.16 | 0.25 | 0.28 | 1.61 | 0.67 | 0.60 | 0.64 | 0 |
| Prev(%) | 39.19 | 41.18 | 81.39 | 82.86 | 92.86 | 92.00 | 93.94 | 87.10 | 95.00 | 0 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes
